Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Inclisiran Approved in Europe for Lowering LDL Cholesterol

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

FDA Grants Stroke Prevention Indication to Ticagrelor

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

November 06, 2020

FDA, EU Clear Fitbit ECG to Detect Atrial Fibrillation

News Daily News

FDA, EU Clear Fitbit ECG to Detect Atrial Fibrillation

Michael O'Riordan

September 15, 2020

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

News Daily News

FDA Approves Next-Generation Watchman FLX Device for LAA Occlusion

July 22, 2020

Cryoballoon Gets FDA Approval for Persistent A-fib

News Daily News

Cryoballoon Gets FDA Approval for Persistent A-fib

June 29, 2020

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

June 01, 2020

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

May 06, 2020

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

February 26, 2020

European Regulators Approve First Transcatheter MV Replacement Device

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.